As with other NSAIDs, an increased risk of gastrointestinal ulceration or other gastrointestinal complications compared to use of celecoxib alone was shown for concomitant administration of low-dose acetylsalicylic acid (see section 5.1).
Nii nagu teiste MSPVA- de puhul, on seedetrakti haavandi oht suurem, kui kasutada tselekoksiibi samaaegselt koos atsetüülsalitsüülhappega (vt lõik 5. 1)